Free Submission Public Relations & NewsPR-inside.com
 
DeutschEnglish

Get the latest news
with our RSS feed
rss feed
Add to My Yahoo!
More information
Business

HCP Declares Quarterly Cash Dividend on Common Stock; Declares Quarterly Cash Dividend on Series E and F Preferred Stock


Print article Print article
Refer this article Refer to a friend
© Business Wire 2008
2008-04-24 23:43:17 -

- HCP (NYSE:HCP) reported that its Board of Directors declared a quarterly common stock cash dividend of $0.455 per share. The dividend will be paid on May 19, 2008 to stockholders of record as of the close of business on May 5, 2008. The annualized rate of distribution for 2008 is $1.82.

In addition, HCP reported that its Board

of Directors declared cash dividends of $0.45313 per share on its Series E cumulative redeemable preferred stock and $0.44375 per share on its Series F cumulative redeemable preferred stock. These dividends will be paid on June 30, 2008 to stockholders of record as of the close of business on June 16, 2008.

About HCP

HCP, Inc., an S&P 500 company, is a self-administered REIT that, together with its consolidated subsidiaries, invests primarily in real estate serving the healthcare industry in the United States. As of December 31, 2007, the Company's portfolio of properties, excluding assets held for sale but including mortgage loans and properties owned by unconsolidated joint ventures, totaled 753 properties among the following segments: 275 senior housing, 105 life science, 269 medical office, 41 hospital and 63 skilled nursing. For more information, visit the Company's website at www.hcpi.com.

HCP
Mark A. Wallace
Executive Vice President -
Chief Financial Officer and Treasurer
562-733-5100




Disclaimer: (c) 2007 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.


Terms & Conditions | About us | Contact PR-inside.com